Olema Pharmaceuticals, Inc. Common Stock
Market Cap
1B
Short interest (Jul 15)
17.3%
Net Short (Jul 27 ): 0.1%
Borrow Fee
0.41%
Available Shares
200K
Price Chart
Company Overview
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.